Wockhardt up 4.5% on US FDA approval for Alzeimers Drug
Wockhardt has got US FDA approval for Alzeimers Drug, reports CNBC-TV18. It touched an intraday high of Rs 186 and an intraday low of Rs 180. At 09:20 am, the share was quoting at Rs 183.70, up Rs 7.95, or 4.52%.